Learning Objectives:
1. Identify reasons for the failure of GLP-1 analogues in obesity management, focusing on adherence, pharmacological resistance, and individual metabolic differences.
2. Compare alternative pharmacological and non-pharmacological strategies for patients who do not respond to GLP-1 analogues.
3. Create holistic management plans that combine behavioral, dietary, exercise, and psychological interventions with other treatments for complex obesity cases.
Session date:
09/19/2024 - 7:00am to 8:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Alisha Wilson, MSN, APRN, FNP-C, CBN

Facebook
X
LinkedIn
Forward